Results 131 to 140 of about 55,246 (249)

Acute limb ischemia in an adolescent with COVID-19 and systemic scleroderma: a case report. [PDF]

BMC Pediatr, 2022
Milan MJDC, Dans LF, Torres-Ticzon VMF.
europepmc   +1 more source

Pathogenesis of Scleroderma (Systemic Sclerosis)

Journal of Investigative Dermatology, 1982
Increasing interest in the vascular features of scleroderma has led to the hypothesis that the blood vessel is the major target tissue and that the endothelial cell is the principal cell target. Useful observations stemming from the vascular hypothesis include the use of microvascular abnormalities in the early detection of the patient destined to ...
openaire   +2 more sources

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, Volume 53, Issue 5, Page 422-426, May 2026.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

A Rare Case of Juvenile Systemic Sclerosis: Clinical Challenges and Management

Annals of Rheumatology and Autoimmunity
Scleroderma is “skleros” sclerosing or hardening of the “derma” skin. It includes both systemic and localized scleroderma (LS). Mostly, juvenile LS affects the skin, whereas juvenile systemic sclerosis (SSc) involves multiple organ systems.
Areej Bano, Shalini Verma, Shrish Bhatnagar   +2 more
doaj   +1 more source

A Case Report of Reversible Cerebral Vasoconstriction Syndrome in a Patient With Systemic Scleroderma. [PDF]

Cureus, 2022
Liu J, Guo M, Beegle RD, Miao R, Manoucheri M.   +4 more
europepmc   +1 more source

Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review. [PDF]

Int J Environ Res Public Health, 2021
Benz K, Baulig C, Knippschild S, Strietzel FP, Hunzelmann N, Jackowski J.   +5 more
europepmc   +1 more source

Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA. [PDF]

An Bras Dermatol, 2022
Liu M.
europepmc   +1 more source

Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast

SAGE Open Medical Case Reports
Localized scleroderma, or morphea, is a chronic fibrosing skin condition with limited therapeutic options, particularly for patients who are elderly, immunocompromized, or intolerant to systemic immunosuppressants.
Ghassan Barnawi, Alexandra Carla Bobica, Hessah BinJadeed, Stephanie Ghazal, Elena Netchiporouk   +4 more
doaj   +1 more source

Photobiomodulation in the treatment of xerostomia associated with hyposalivation in a pediatric patient with systemic scleroderma. [PDF]

Autops Case Rep, 2021
de Oliveira AB, Ferrisse TM, Salomão KB, Miranda ML, Bufalino A, Brighenti FL.   +5 more
europepmc   +1 more source

National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations

Arthritis &Rheumatology, Volume 78, Issue 5, Page 1032-1037, May 2026.
Ram Raj Singh
wiley   +1 more source